Beurs gesloten -
Japan Exchange
08:00:00 17-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
655
JPY
|
-1,06%
|
|
-4,66%
|
+15,52%
|
Fiscaal tijdperk: december |
2020 Q3
|
2021 Q1
|
2021 Q3
|
2022 Q1
|
2022 Q3
|
2023 Q1
|
---|
Omzet
1 |
71
|
62
|
125
|
193
|
358
|
35
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-507
|
-349
|
-330
|
-384
|
-279
|
-325
|
Operationele Marge
|
-714,08%
|
-562,9%
|
-264%
|
-198,96%
|
-77,93%
|
-928,57%
|
Resultaat voor belastingen (EBT)
1 |
-880
|
-349
|
-327
|
-328
|
-264
|
-322
|
Nettowinst (verlies)
1 |
-881
|
-350
|
-329
|
-328
|
-265
|
-323
|
Nettomarge
|
-1.240,85%
|
-564,52%
|
-263,2%
|
-169,95%
|
-74,02%
|
-922,86%
|
WPA
2 |
-61,21
|
-22,36
|
-18,97
|
-18,98
|
-15,28
|
-18,69
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
06-11-20
|
07-05-21
|
05-11-21
|
13-05-22
|
04-11-22
|
12-05-23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +15,52% | 89 mln. | | -2,32% | 92,59 mld. | | +3,68% | 41,43 mld. | | -10,90% | 33,49 mld. | | -19,56% | 14,62 mld. | | -9,06% | 12,77 mld. | | -11,34% | 11,58 mld. | | -43,53% | 11,35 mld. | | +3,75% | 8,97 mld. | | -6,32% | 8,3 mld. |
Biofarmaceutica
|